T1	CHEM 13 18	cobre
#1	AnnotatorNotes T1	C0009968; copper; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T2	DISO 382 405	colonización bacteriana
#2	AnnotatorNotes T2	C2747813; Bacterial colonisation; Finding
T3	DISO 38 68	infecciones intrahospitalarias
#3	AnnotatorNotes T3	C0010356; Cross Infection; Disease or Syndrome | C0205721; Infections, Hospital; Disease or Syndrome
T4	CHEM 92 107	antimicrobianos
#4	AnnotatorNotes T4	C0003204; Anti-Infective Agents; Pharmacologic Substance
T5	DISO 174 198	infecciones nosocomiales
#5	AnnotatorNotes T5	C0010356; Cross Infection; Disease or Syndrome | C0205721; Infections, Hospital; Disease or Syndrome
T6	CHEM 286 291	cobre
#6	AnnotatorNotes T6	C0009968; copper; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T7	CHEM 495 500	cobre
#7	AnnotatorNotes T7	C0009968; copper; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T8	DISO 526 556	infecciones intrahospitalarias
#8	AnnotatorNotes T8	C0010356; Cross Infection; Disease or Syndrome | C0205721; Infections, Hospital; Disease or Syndrome
T9	DISO 587 617	infecciones intrahospitalarias
#9	AnnotatorNotes T9	C0010356; Cross Infection; Disease or Syndrome | C0205721; Infections, Hospital; Disease or Syndrome
T10	CHEM 634 649	antimicrobianos
#10	AnnotatorNotes T10	C0003204; Anti-Infective Agents; Pharmacologic Substance
T11	PROC 663 684	hospitalizados en UCI
#11	AnnotatorNotes T11	C5419131; Intensive Care Unit Stay; Health Care Activity
T12	PROC 748 780	Estudio prospectivo, comparativo
#12	AnnotatorNotes T12	C1579762; comparative study research; Research Activity + C0033522; Prospective Studies; Research Activity
T13	PROC 851 868	ingresados en UCI
#13	AnnotatorNotes T13	C5419131; Intensive Care Unit Stay; Health Care Activity
T14	CHEM 989 994	cobre
#14	AnnotatorNotes T14	C0009968; copper; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T15	CHEM 1091 1096	cobre
#15	AnnotatorNotes T15	C0009968; copper; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T16	CHEM 1119 1124	cobre
#16	AnnotatorNotes T16	C0009968; copper; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T17	DISO 1184 1214	infecciones intrahospitalarias
#17	AnnotatorNotes T17	C0010356; Cross Infection; Disease or Syndrome | C0205721; Infections, Hospital; Disease or Syndrome
T18	DISO 1298 1338	neumonía asociada a ventilación mecánica
#18	AnnotatorNotes T18	C1701940; Pneumonia, Ventilator-Associated; Disease or Syndrome | C2189270; VABP; Disease or Syndrome
T19	PROC 1318 1338	ventilación mecánica
#19	AnnotatorNotes T19	C0199470; Mechanical ventilation; Therapeutic or Preventive Procedure
T20	DISO 1350 1396	infección urinaria asociada a catéter urinario
#20	AnnotatorNotes T20	C3838785; Catheter-associated urinary tract infection; Pathologic Function
T21	DISO 1409 1454	bacteremias asociada a catéter venoso central
#21	AnnotatorNotes T21	C1328352; Catheter bacteraemia; Disease or Syndrome
T22	DISO 1526 1535	infección
#22	AnnotatorNotes T22	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T23	CHEM 1577 1592	antimicrobianos
#23	AnnotatorNotes T23	C0003204; Anti-Infective Agents; Pharmacologic Substance
T24	CHEM 1643 1648	cobre
#24	AnnotatorNotes T24	C0009968; copper; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T25	CHEM 1807 1812	cobre
#25	AnnotatorNotes T25	C0009968; copper; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T26	DISO 1905 1916	bacteriemia
#26	AnnotatorNotes T26	C0004610; Bacteremia; Disease or Syndrome
T28	DISO 2001 2010	neumonías
#27	AnnotatorNotes T28	C0032285; Pneumonia; Disease or Syndrome
T29	DISO 2013 2034	infecciones urinarias
#28	AnnotatorNotes T29	C0042029; Urinary tract infection; Disease or Syndrome
T30	CHEM 2160 2175	antimicrobianos
#29	AnnotatorNotes T30	C0003204; Anti-Infective Agents; Pharmacologic Substance
T31	PROC 809 829	Asignación aleatoria
#30	AnnotatorNotes T31	C0034656; Randomization; Research Activity
T32	ANAT 1360 1368	urinaria
#31	AnnotatorNotes T32	C1508753; Urinary system; Body System
T35	ANAT 2025 2034	urinarias
#32	AnnotatorNotes T35	C1508753; Urinary system; Body System
T36	LIVB 147 154	adultos
#33	AnnotatorNotes T36	C0001675; Adult; Age Group
T38	LIVB 361 370	pacientes
#34	AnnotatorNotes T38	C0030705; Patients; Patient or Disabled Group
T39	LIVB 395 405	bacteriana
#35	AnnotatorNotes T39	C0004611; Bacteria; Bacterium
T40	LIVB 653 662	pacientes
#36	AnnotatorNotes T40	C0030705; Patients; Patient or Disabled Group
T41	LIVB 685 692	adultos
#37	AnnotatorNotes T41	C0001675; Adult; Age Group
T42	LIVB 727 736	Pacientes
#38	AnnotatorNotes T42	C0030705; Patients; Patient or Disabled Group
T43	Date 782 794	mayo de 2011
T44	Date 795 807	mayo de 2012
T45	LIVB 833 850	pacientes adultos
#39	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group + C0001675; Adult; Age Group
T47	Duration 888 905	al menos por 24 h
T48	Neg_cue 970 972	no
T49	LIVB 1042 1051	pacientes
#40	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T50	LIVB 1057 1066	pacientes
#41	AnnotatorNotes T50	C0030705; Patients; Patient or Disabled Group
T51	Neg_cue 1087 1090	sin
T54	DEVI 1380 1396	catéter urinario
#42	AnnotatorNotes T54	C0179802; Urinary catheter; Medical Device
T55	DEVI 1432 1454	catéter venoso central
#43	AnnotatorNotes T55	C1145640; Central venous catheter, device; Medical Device
T58	Neg_cue 1517 1525	libre de
T59	LIVB 1596 1605	pacientes
#44	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T63	DEVI 1928 1948	dispositivos venosos
#45	AnnotatorNotes T63	C1145640; Central venous catheter, device; Medical Device
T69	LIVB 2179 2188	pacientes
#46	AnnotatorNotes T69	C0030705; Patients; Patient or Disabled Group
A1	Population_data T36 Age
A2	Population_data T41 Age
A3	Population_data T45 Age
A4	Assertion T14 Negated
A5	Assertion T15 Negated
A6	Assertion T22 Negated
R1	Negation Arg1:T51 Arg2:T15	
R2	Negation Arg1:T48 Arg2:T14	
T27	Neg_cue 1134 1136	No
T33	CONC 1152 1163	diferencias
A7	Assertion T33 Negated
#47	AnnotatorNotes T33	C1705241; Delta (difference); Quantitative Concept
R3	Negation Arg1:T27 Arg2:T33	
R4	Negation Arg1:T58 Arg2:T22	
T34	Neg_cue 1735 1737	no
T37	CONC 1723 1734	diferencias
#48	AnnotatorNotes T37	C1705241; Delta (difference); Quantitative Concept
T46	Quantifier_or_Qualifier 1738 1752	significativas
A8	Assertion T46 Negated
#49	AnnotatorNotes T46	C0750502; Significant; Idea or Concept
R5	Has_Quantifier_or_Qualifier Arg1:T37 Arg2:T46	
R6	Negation Arg1:T34 Arg2:T46	
T52	CONC 2040 2051	diferencias
T53	Quantifier_or_Qualifier 2055 2069	significativas
A9	Assertion T53 Negated
#50	AnnotatorNotes T53	C0750502; Significant; Idea or Concept
T56	Neg_cue 2052 2054	no
R7	Negation Arg1:T56 Arg2:T53	
#51	AnnotatorNotes T52	C1705241; Delta (difference); Quantitative Concept
R8	Has_Quantifier_or_Qualifier Arg1:T52 Arg2:T53	
T57	Quantifier_or_Qualifier 2204 2214	cobrizadas
A10	Assertion T57 Negated
T60	Neg_cue 2201 2203	no
R9	Negation Arg1:T60 Arg2:T57	
T61	Observation 2094 2129	se completó el tamaño de la muestra
A11	Assertion T61 Negated
T62	Neg_cue 2091 2093	no
R10	Negation Arg1:T62 Arg2:T61	
T64	Quantifier_or_Qualifier 1960 1973	significativa
A12	Assertion T64 Negated
#52	AnnotatorNotes T64	C0750502; Significant; Idea or Concept
T65	Neg_cue 1957 1959	no
R11	Negation Arg1:T65 Arg2:T64	
T66	CONC 1987 1997	diferencia
A13	Assertion T66 Negated
#53	AnnotatorNotes T66	C1705241; Delta (difference); Quantitative Concept
T67	Neg_cue 1977 1979	no
R12	Negation Arg1:T67 Arg2:T66	
T68	Neg_cue 1681 1683	no
T70	Observation 1684 1716	se completó el tamaño de muestra
A14	Assertion T70 Negated
R13	Negation Arg1:T68 Arg2:T70	
T71	Neg_cue 1232 1239	Tampoco
T72	Neg_cue 1466 1473	Tampoco
T73	CONC 1255 1266	diferencias
A15	Assertion T73 Negated
#54	AnnotatorNotes T73	C1705241; Delta (difference); Quantitative Concept
R14	Negation Arg1:T71 Arg2:T73	
T74	CONC 1489 1500	diferencias
#55	AnnotatorNotes T74	C1705241; Delta (difference); Quantitative Concept
R15	Negation Arg1:T72 Arg2:T74	
T76	CONC 70 80	mortalidad
#57	AnnotatorNotes T76	C0085556; Hospital Mortality; Qualitative Concept
T77	CONC 83 88	gasto
#58	AnnotatorNotes T77	C0220812; Cost aspects; Functional Concept
R17	Experiences Arg1:T36 Arg2:T3	
R18	Experiences Arg1:T36 Arg2:T4	
T78	CONC 214 224	mortalidad
#59	AnnotatorNotes T78	C0085556; Hospital Mortality; Qualitative Concept
T79	CONC 227 233	costos
#60	AnnotatorNotes T79	C0220812; Cost aspects; Functional Concept
R20	Experiences Arg1:T38 Arg2:T2	
R22	Causes Arg1:T39 Arg2:T2	
T83	CONC 561 571	mortalidad
#64	AnnotatorNotes T83	C0085556; Hospital Mortality; Qualitative Concept
R25	Experiences Arg1:T40 Arg2:T10	
R26	Experiences Arg1:T40 Arg2:T9	
R27	Experiences Arg1:T40 Arg2:T8	
R29	Experiences Arg1:T41 Arg2:T10	
R30	Experiences Arg1:T41 Arg2:T9	
R31	Experiences Arg1:T41 Arg2:T8	
R33	Overlap Arg1:T10 Arg2:T11	
R34	After Arg1:T12 Arg2:T43	
R35	Before Arg1:T12 Arg2:T44	
R37	Has_Duration_or_Interval Arg1:T13 Arg2:T47	
R38	Before Arg1:T31 Arg2:T14	
R39	Overlap Arg1:T13 Arg2:T14	
T84	Observation 1016 1037	Ingresaron al estudio
#65	AnnotatorNotes T84	C1278516; Patient participation status; Finding (?)
R40	Experiences Arg1:T49 Arg2:T84	
R41	Experiences Arg1:T50 Arg2:T84	
R42	Overlap Arg1:T18 Arg2:T19	
R43	Location_of Arg1:T32 Arg2:T20	
R44	Overlap Arg1:T20 Arg2:T54	
R45	Overlap Arg1:T21 Arg2:T55	
T85	CONC 1507 1516	sobrevida
T86	Quantifier_or_Qualifier 1517 1535	libre de infección
R46	Has_Quantifier_or_Qualifier Arg1:T85 Arg2:T86	
T87	CONC 1562 1573	gasto menor
#66	AnnotatorNotes T87	C0085550; Cost Savings; Quantitative Concept (?)
R47	Experiences Arg1:T59 Arg2:T23	
R50	Overlap Arg1:T26 Arg2:T63	
R54	Location_of Arg1:T35 Arg2:T29	
T89	CONC 2151 2156	gasto
#68	AnnotatorNotes T89	C0220812; Cost aspects; Functional Concept
R56	Experiences Arg1:T69 Arg2:T30	
T90	CONC 624 630	costos
#69	AnnotatorNotes T90	C0220812; Cost aspects; Functional Concept
T91	Quantifier_or_Qualifier 1267 1281	significativas
A16	Assertion T91 Negated
#70	AnnotatorNotes T91	C0750502; Significant; Idea or Concept
R24	Has_Quantifier_or_Qualifier Arg1:T73 Arg2:T91	
R28	Negation Arg1:T71 Arg2:T91	
R16	Experiences Arg1:T41 Arg2:T11	
R19	Experiences Arg1:T40 Arg2:T11	
R21	Experiences Arg1:T45 Arg2:T13	
#56	AnnotatorNotes T85	C0220921; survival aspects; Functional Concept
R23	Overlap Arg1:T26 Arg2:T28	
R32	Overlap Arg1:T26 Arg2:T29	
A17	Experiencer T36 Patient
A18	Experiencer T38 Patient
A19	Experiencer T40 Patient
A20	Experiencer T41 Patient
A21	Experiencer T42 Patient
A22	Experiencer T45 Patient
A23	Experiencer T50 Patient
A24	Experiencer T49 Patient
A25	Experiencer T59 Patient
A26	Experiencer T69 Patient
